Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al

Affiliations

Comment

Ali T Taher. Br J Haematol. 2017 Mar.

. 2017 Mar;176(6):989-990.

doi: 10.1111/bjh.14018. Epub 2016 Mar 11.

¹ Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

No abstract available

Keywords: chelation therapy; iron overload; liver iron concentration; non-transfusion-dependent thalassaemia; serum ferritin.

Comment on

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Origa R, Karakas Z, Habr D, Zhu Z, Cappellini MD. Taher AT, et al. Br J Haematol. 2015 Jan;168(2):284-90. doi: 10.1111/bjh.13119. Epub 2014 Sep 12. Br J Haematol. 2015. PMID: 25212456 Clinical Trial.
HbH Constant Spring disease has lower serum ferritin relative to liver iron concentration (LIC): importance of LIC measurement and potential impact on serum ferritin thresholds for iron chelation.
Ang AL, Le TT, Tan RS. Ang AL, et al. Br J Haematol. 2017 Mar;176(6):986-988. doi: 10.1111/bjh.14013. Epub 2016 Mar 15. Br J Haematol. 2017. PMID: 26991009 No abstract available.